SCHULTZ @ANACONDAFINANC1
Joined August 2015-
Tweets2K
-
Followers224
-
Following53
-
Likes8K
$AFMD
Sunday story from me. Important enough not to wait for Monday. $MOR $NVS New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition statnews.com/2024/04/28/mor…
$AFMD : will AFM13+ Artiva replicate the data from MD Anderson ? Comments from Andreas on August 2023
$SAN $SNY mainly open to $2-5bn bolt-on's
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer artivabio.com/artiva-biother… #AlloNK #NKcell #NKcells #autoimmunedisease #lupus
$RHHBY stressing that termination of 20% of NMEs is a gross figure. Other projects have been added, including through M&A.
@Banana_Oncology @zen_tropy @Season11031 @maddstone1 @pfzhang008 @ny1972_47 @biotech_cash You got it - it is selective(!) to EGFR+ independent of mutations without interfering with its signaiing pathway instead eliminates those cancer cells via engaging NK cells for direct killing and debris-eating macrophages for phagocytosis. Compared to mAb it is safe always works.
another day, another "Sanofi cuts X" $SAN $SNY x.com/FierceBiotech/…
another day, another "Sanofi cuts X" $SAN $SNY x.com/FierceBiotech/…
$AFMD
@Banana_Oncology @maddstone1 @Season11031 @ny1972_47 @biotech_cash this shift in the macrophage population could alter the TME in a way that, in conjunction with PD-L1 mediated pathways, enhances T cell activation. The activated T cells could then release further quantities of IFN-γ and TNF-α, thereby creating a positive feedback loop
$AFMD 👍
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis artivabio.com/artiva-biother… #AlloNK #NKcell #NKcells #clinicaltrials #clinicaltrial #autoimmunedisease #autoimmunity
What kind of response is that
Tour de force presentation today by Dr. Katy Rezvani @lab_rezvani at the Allison Institute @MDAndersonNews encompassing great science and a proliferative pipeline of cell therapies for our patients with heme and solid cancers! #NK #celltherapy
$AFMD P2 in mono , not with NK cells since Kiadis is out !
$AFMD P2 in mono , not with NK cells since Kiadis is out !
Two Brothers, a Big #Biotech Bet, and an $8 Billion Payout. 💥 msn.com/en-us/money/co…
We are proud that data from the Phase 2 TELLOMAK Sézary syndrome cohort will be presented as an encore presentation at the World Congress of Cutaneous Lymphomas by Youn H. Kim, MD. More info 👉 cme.cityofhope.org/content/5th-wo… #InnatePharma #SezarySyndrome #CutaneousLymphomas
$ADAP $RHHBY sadtombone adaptimmune.com/investors-and-…
`((,(Dieter 'Hovekamp.. @dhovekamp42
4K Followers 2K Following born to be me, expect the worst - go for the best { views are my own - tweets are not advice }
Duikb00t @duikb00t
332 Followers 397 Following Biotech Risk; Top picks: $ARWR / $AFMD / $ADAP / $LPTX Long-term: Non-Bio: #GBL / #SOFINA / #AGEAS / #APAM / #DIS
Getoutofmyway @Getoutofmyway1
2K Followers 2K Following I take cursing in traffic to the next level. Lemon cake is my weakness. https://t.co/NP6dTVt10G
Listing56 @LlSTlNG56
519 Followers 542 Following Post n’engageant que moi, et ne devant pas être pris comme une incitation à suivre, vendre ou acheter une valeur. Sur X pour suivi macro, biotech 🧬 et infos 📰
EOMESBiotech @eomes_biotech
912 Followers 475 Following Science & biotech, VC, l/s views, No investment advice, DYODD.
Aesculapius1898 @Aesculapius1898
528 Followers 1K Following No investment recommedations. No financial advices. Do your own Due Diligence. Tweets are for my own education and entertainment only.
Smalls @Abby10Smalls
1K Followers 723 Following Abby is my dog. I'm an investor with a primary focus on small cap companies. Tweets are not advice. Do your own DD.
Season1103 @Season11031
12 Followers 12 Following
Cam McCrady @cammunicate
125 Followers 1K Following Live in SF. Like the fog. Former @spacecurve, @socialthinking, etc.
German Fella @German_Fella
244 Followers 394 Following 🇩🇪 #NAFO #fella 🇺🇦 #SlavaUkraïni #СлаваУкраїні Hates terrorism. 🇮🇱
john snow @pigger5
117 Followers 526 Following
efar @efarev
238 Followers 736 Following Biotech Swing trader (mostly) playing ahead of catalysts. Also interested in longer-term Biotech Value plays.
Ex_Citizen_BuckTweet .. @GuyGadboisGuyG1
3K Followers 2K Following Sharing thoughts on politics, culture & stocks. 100% Peaceful Tweeter. It’s OK to be very uncomfortable. Vulgar, much swearing. Cynical AF. Be Skeptical.
wmtomlinson @s86CoffeeDev
162 Followers 951 Following
linhdtu @tuduylinh
357 Followers 390 Following
Simone Ortolani @siormilan
47 Followers 244 Following
TrentGlowacky @TGlowacky46851
106 Followers 2K Following
Frank Wei @FrankWe62646092
82 Followers 651 Following
tim finn @macktavish
625 Followers 5K Following
Frank Wei @FrankWe50609546
65 Followers 853 Following
HODOR @Maximus_Holl_a
260 Followers 4K Following Swing & day trader Tweets are my opinion only and not a recommendation to buy or sell any security. Parody account!
Business_SWOT_Lab @SwotLab
64 Followers 29 Following 🌟 Investor & Business Strategist | Sharing Wisdom | Insightful Analysis
Dirk Haussecker @RNAiAnalystz
71 Followers 688 Following Natural born biotech stock trader/investor. Trained in RNAi, extremely excited about RNA Editing. Not investment advice
Arjen Smid @ArjenS92119
18 Followers 47 Following
CDx @GenomeBiomarker
242 Followers 511 Following Developing companion diagnostics for oncology drugs.
Steph Pitt @pitt_pitt4
2 Followers 9 Following
Gilbert Kohnke @gilkohnke
101 Followers 825 Following Surround yourself with people who push you to become the best version of yourself.
Adam Yusim @AdamYusim8
99 Followers 369 Following
Niencke @Opnaartenerife
48 Followers 102 Following
mikiass @mikiass0
59 Followers 658 Following
Messenger Bio @MessengerBio
11 Followers 63 Following Biotech startup focused on industrialising the discovery of novel mRNA medicines. Providing mRNA to researchers as well as developing our own unique offerings.
Rex Wiggins @RexWiggins12
2K Followers 5K Following Career Venture Capitalist/ private investor. M&A biotech
David x @JJ_BIO_MAX
299 Followers 367 Following
Thushara Jayasekera @ThusharaJayase3
1K Followers 4K Following Designer by day, musician by night, and always spreading positivity. Join me as I navigate the world of hospitality and strive to become a billionaire. #inspire
Bin @v074724
0 Followers 364 Following
David Oberlander @DavidOberl79732
18 Followers 37 Following Neurologist with an interest in innate immunity
👑 Eligwe @KingEligwe
63 Followers 644 Following I am a superior man whose action is exceed but modest in speech
Ricardo Sanz @jhonatan_rsm
24 Followers 600 Following
Quentin Clark @qclark12
104 Followers 434 Following
Squidfest @CapeSquidfest
105 Followers 1K Following Wellfleet, Cape Cod, MA Founder, Squidfest Squid Ink Artist Proud Baltimoron and Cape Washashore
george @mopgcw
205 Followers 807 Following
Pixbillye @YMuer
298 Followers 288 Following SO LONG AS YOU HAVE FOOD IN YOUR MOUTH, YOU HAVE SOLVED ALL QUESTIONS FOR THE TIME BEING.
CortoMinos @CortoMinos
87 Followers 105 Following "La seule révolution possible, c'est d'essayer de s'améliorer soi-même en espérant que les autres fassent la même démarche ... C'est le seul chemin" G. Brassens
Heinous MacTavish @HeinousMacT
1K Followers 5K Following 🇺🇸 US Naval Academy/Stanford U./U. Michigan. RNA Editing/Disruptive Tech.🚫Woke LibTard Marxists/Socialists. Bloated🇷🇺🐀-Faced Midget Satan Must Pay/Die☠️.
Adeel Mirza @2001_adeel
309 Followers 3K Following
Sean O'Shea @seanardee
17 Followers 290 Following
marketreader @marketreader8
116 Followers 202 Following Ivy Leaguer biologist and pharma executive. All my opinions are BIASED, not investment advice! Do your own critical thinking and DD.
As @Azz12103
261 Followers 5K Following
`((,(Dieter 'Hovekamp.. @dhovekamp42
4K Followers 2K Following born to be me, expect the worst - go for the best { views are my own - tweets are not advice }
Duikb00t @duikb00t
332 Followers 397 Following Biotech Risk; Top picks: $ARWR / $AFMD / $ADAP / $LPTX Long-term: Non-Bio: #GBL / #SOFINA / #AGEAS / #APAM / #DIS
Bertrand Delsuc @BertrandBio
16K Followers 253 Following Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design) & a bit of Bio :)
Affimed @affimed
785 Followers 127 Following We are a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer.
Listing56 @LlSTlNG56
519 Followers 542 Following Post n’engageant que moi, et ne devant pas être pris comme une incitation à suivre, vendre ou acheter une valeur. Sur X pour suivi macro, biotech 🧬 et infos 📰
Innate Pharma @InnatePharma
4K Followers 278 Following #Biotech #Immunotherapy #ImmunoOncology #Cancer #Inflammation #Antibody #Checkpoints
EOMESBiotech @eomes_biotech
912 Followers 475 Following Science & biotech, VC, l/s views, No investment advice, DYODD.
Aesculapius1898 @Aesculapius1898
528 Followers 1K Following No investment recommedations. No financial advices. Do your own Due Diligence. Tweets are for my own education and entertainment only.
RNA_Biotech @RNA_Biotech
2K Followers 163 Following Stocks - Biotech - RNAi, mRNA, RNA tech, gene therapy, NK + cell therapies, CRISPR - opinions, news, trading. Top Picks for 2024 $MDNAF $MDNA (.to) $AFMD $ACET
Banana Oncology @Banana_Oncology
249 Followers 232 Following - Academic/Pharma veteran - Oncology & I/O - Identifying asymmetric bets through scientific/financial deep dives - Not financial advises - Here to learn
Porter @pfzhang008
4 Followers 8 Following
volsareback @mil30557647
62 Followers 172 Following
Steph Pitt @pitt_pitt4
2 Followers 9 Following
Season1103 @Season11031
12 Followers 12 Following
Dirk Haussecker @RNAiAnalystz
71 Followers 688 Following Natural born biotech stock trader/investor. Trained in RNAi, extremely excited about RNA Editing. Not investment advice
Jim DuboisKitchen @jdubois1234
35 Followers 0 Following
ArtivaBio @ArtivaBio
299 Followers 42 Following We are dedicated to making safe and effective cell therapies accessible to any cancer patient who may benefit. #NKcelltherapy #celltherapy #cancer #NKcells
Bon Wood @ny1972_47
339 Followers 23 Following
David Oberlander @DavidOberl79732
18 Followers 37 Following Neurologist with an interest in innate immunity
Pixbillye @YMuer
298 Followers 288 Following SO LONG AS YOU HAVE FOOD IN YOUR MOUTH, YOU HAVE SOLVED ALL QUESTIONS FOR THE TIME BEING.
David oberlander @Davidoberland12
80 Followers 112 Following Neurologist with an interest in innate immunity.
Christian Breunig @breunig_c
120 Followers 222 Following Cell biologist / Immunologist. Research Project Leader at Affimed GmbH. Views are my own.
Omar @radioonc
27 Followers 85 Following #Radiation oncologist investing in biotech. Tweets are my opinion
smarting1121 @smarting1121
42 Followers 69 Following
Affivant @affivant
85 Followers 58 Following Affivant is dedicated to developing novel immune-oncology approaches to enable the immune system to fight cancer.
Alain BRAU @ArkaLei
506 Followers 472 Following
Davey Jones Locker @oceanabyss7
103 Followers 450 Following Energy, shipping, emerging markets, small biotech. Tweets for entertainment only, do your own DD.
maddstone🇮🇱 @maddstone1
183 Followers 74 Following
US CARS KUNTZ @uscarskuntz
12 Followers 74 Following US CARS KUNTZ spécialisé dans l'import homologation, francisation, achat, vente, passage UTAC,DREAL ,RTI, américaines, implanté depuis 1994 à Dachstein 67120
machbaer @PhilippBaer1
98 Followers 107 Following Protein Engineer - Display Technologies - Antibodies - Nanobodies
🇺🇦Mottekk242 @mottekk242
126 Followers 399 Following Biotech investor 💊 🦠 🧬🧫 💉🔬 Tweets are my opinion, not investment advice
LagunaRay @Long6422Da
57 Followers 85 Following All tweets are opinions and questions only. Not advice.
GAULTIER gregory @GregoryGAULTIER
438 Followers 9 Following
stephane dubail @stephane_dubail
177 Followers 973 Following
Ward Kennes @wardkennes
516 Followers 1K Following Webdeveloper at LDL Communication https://t.co/9CPCAI6x9w Laravel - PHP - VueJS -
Larry Hsin @xlp007
1K Followers 309 Following Biotech investor, Cell therapy, Gene editing, RNAi and PROTACs
ATCG_Partners @ATCGPartners
455 Followers 290 Following A full services #communication and #marketing french agency specialized in #biomedicine, from bench to bedside and across disciplines
Quantum Genomics @QuantumGenomics
2K Followers 105 Following Société biopharmaceutique développant de nouvelles thérapies pour des besoins médicaux non satisfaits dans le domaine des maladies cardiovasculaires #Biotech
Cathy Terroine @CTerroine
13 Followers 33 Following
financimm @financesaz
110 Followers 348 Following "Ce qui me bouleverse, ce n'est pas que tu m'aies menti, c'est que désormais, je ne pourrai plus te croire." Nietzsche.
florian PERALDI @florianPERALDI
56 Followers 126 Following Administrateur de sociétés spécialisé en Acquisition, arbitrage et cession d'actif immobilier. une information, un conseil n'hésitez pas à prendre contact...
Promising Results from the AFM24 Clinical Study in Combination with Atezolizumab Presented at ASCO Annual Meeting: $AFMD Affimed N.V., a clinical-stage immuno-oncology company,… dlvr.it/T5xHv8 #AFM24 #MajorPharmaceuticalPreparations #AffimedNv #AFMD #competitors
@jdubois1234 @affimed Well preclinical stuff have been dropped so inevitable. If data plays out they have a tech to sell.
@zen_tropy increased EGFR signaling in lung cancer cells may elevate the expression of anti-apoptotic MCL-1 and cIAP-2 genes, potentially through the downregulation of miR-29a-3p and miR-143-3p docwirenews.com/post/role-of-m…
@zen_tropy @eomes_biotech @RayLagunabb @ANACONDAFINANC1 $afmd LuminICE is on autopilot at the moment, there is nothing to do but wait for the results.With the 24 trials, Harstrick's experience is desperately needed.And given the financial situation, I don't think they are actively looking for anyone because they simply can't afford it
@Season11031 Compare this dismal data to NSCLC, the dominant players are reg lymphocytes in the cervix. Depleting TAM resulted in marginal impact.
@ANACONDAFINANC1 Why not? Same elephant 😀 Cell type Total number 95% CI Total mass [g] NK cells 2 × 10B 0.9–4 × 10B 4 Macrophages 2 × 100B 1.3–3 × 100B 600
@ny1972_47 @maddstone1 @zen_tropy @DmitryKovalchuk @dragonflytx Question is: is it need more engineering (ie Trispecific) for engagers ? Affimed did abandon their Trispecific assets years ago and it focused on its bispecific claiming the highest -affinity binding and no interference with IgG
@RNA_Biotech @ANACONDAFINANC1 @RayLagunabb @eomes_biotech I think this one will be different, Hit or miss!
Innate Checkpoints 🍴NK Cells 🍴Innate Engagers 🍴Cytokines We would not necessarily place cytokines on the list, but we understand the indirect link. We would add myeloid checkpoints (e.g., LILRBs, etc.) H/T Jeff Martin from the HR social channel
@maddstone1 @8thKingofRome @zen_tropy @DmitryKovalchuk @dragonflytx Not really. 13 was pretty effective in AITL. 0 expectation anyway.
@8thKingofRome @ny1972_47 @zen_tropy @DmitryKovalchuk @dragonflytx No one knows the answer! Not even Dieter. But as there is place for a plethora of ADC Vendors there will be enough space for 3 NGEngager Players $afmd
@zen_tropy @ny1972_47 @maddstone1 @DmitryKovalchuk @8thKingofRome @dragonflytx Riding a German ICE has most comfort, is safe, fast and flexible (if it is not delayed or canceled due to mis-management of Deutsche Bahn / Affimed)
@zen_tropy @maddstone1 @DmitryKovalchuk @8thKingofRome @dragonflytx Race? Engaging foot soldiers only not going to win a war. Targeting macrophages is the key where TAM dominates. This dragonfly is going to fall like the CARNK bios.
@ny1972_47 @maddstone1 @DmitryKovalchuk @8thKingofRome @dragonflytx $afmd Would you rather ride a BiKE or a TRiKE to victory in nsclc and/or aml? Went to have a look at Dragonfly's pipeline. Didn't realize they had a wholly-owned egfr-targeting Trinket (binding I'm assuming CD16/nkg2d), focused on solid tumors, including nsclc. Meanwhile, $sny /…
@Eddie_Cliff @benjaminsutu @EBRheum @DrCMcMaster Completely agree we have to watch with interest. Autologous CAR-T, allogenic CAR-T, bi-specifics, CD8 and NK engagers....which will have the best combination of efficacy and safety (and cost)?
@zen_tropy @ny1972_47 @RNA_Biotech oh, look at the safety there @zen_tropy....or the lack of
@ANACONDAFINANC1 @RayLagunabb @eomes_biotech $afmd I think there will be a company event for the other 3 programs.
@RayLagunabb @ANACONDAFINANC1 @eomes_biotech yes, they know more than we do...Always. FWIW, asco application timelines limit follow up from what we saw already and therefore what we know of current data... This implies the success -if any-will not show in abstract on May 23 but will be in poster at ASCO on June 1...
Trends for United States
You might like
